IL73230A0 - Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins - Google Patents

Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins

Info

Publication number
IL73230A0
IL73230A0 IL73230A IL7323084A IL73230A0 IL 73230 A0 IL73230 A0 IL 73230A0 IL 73230 A IL73230 A IL 73230A IL 7323084 A IL7323084 A IL 7323084A IL 73230 A0 IL73230 A0 IL 73230A0
Authority
IL
Israel
Prior art keywords
bicyclicpyridinium
relating
cephalosporins
methyl
methyl cephalosporins
Prior art date
Application number
IL73230A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL73230A0 publication Critical patent/IL73230A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/48—Methylene radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IL73230A 1983-10-17 1984-10-14 Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins IL73230A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54261983A 1983-10-17 1983-10-17

Publications (1)

Publication Number Publication Date
IL73230A0 true IL73230A0 (en) 1985-01-31

Family

ID=24164603

Family Applications (1)

Application Number Title Priority Date Filing Date
IL73230A IL73230A0 (en) 1983-10-17 1984-10-14 Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins

Country Status (17)

Country Link
EP (1) EP0138552A3 (fr)
JP (1) JPS60105685A (fr)
KR (1) KR850002992A (fr)
AU (1) AU574107B2 (fr)
CA (1) CA1225390A (fr)
DK (1) DK489184A (fr)
ES (1) ES536728A0 (fr)
FI (1) FI844000A7 (fr)
GB (2) GB2148289B (fr)
GR (1) GR80670B (fr)
HU (1) HU195512B (fr)
IL (1) IL73230A0 (fr)
NZ (1) NZ209833A (fr)
PH (1) PH21040A (fr)
PT (1) PT79357B (fr)
SU (1) SU1360587A3 (fr)
ZA (1) ZA847926B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH22107A (en) * 1984-06-07 1988-06-01 Takeda Chemical Industries Ltd 3-pyrazolo(1,5-a)pyrdinium cephem compounds
US4734408A (en) * 1986-12-17 1988-03-29 Eli Lilly And Company Crystalline cephalosporin antibiotic salts and solvates
EP0304858A3 (fr) * 1987-08-25 1989-12-20 Takeda Chemical Industries, Ltd. Composés céphem, leur préparation et utilisation
TW526202B (en) 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
AT412214B (de) * 1999-05-05 2004-11-25 Sandoz Ag Verfahren zur herstellung des dinatrium-hemiheptahydratsalzes von ceftriaxon
GB0215293D0 (en) 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
DK2161273T3 (en) 2003-12-22 2015-07-20 Leuven K U Res & Dev Imidazo [4,5-C] pyridine compounds and methods for antiviral therapy
PT1841765E (pt) 2004-12-21 2009-05-14 Gilead Sciences Inc Anticorpos para mcp-1 humano
US7754720B2 (en) 2006-07-07 2010-07-13 Gilead Sciences, Inc. Pyridazine compound and use thereof
UA99466C2 (en) 2007-07-06 2012-08-27 Гилиад Сайенсиз, Инк. Crystalline pyridazine compound
US20140275000A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Ceftolozane pharmaceutical compositions
KR102329764B1 (ko) 2013-03-15 2021-11-23 머크 샤프 앤드 돔 코포레이션 세프톨로잔 항균성 조성물
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
US10376496B2 (en) 2013-09-09 2019-08-13 Merck, Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane
EP3801503A4 (fr) 2018-06-07 2021-12-08 Disarm Therapeutics, Inc. Inhibiteurs de sarm1
JP7478142B2 (ja) * 2018-06-07 2024-05-02 ディスアーム セラピューティクス， インコーポレイテッド Ｓａｒｍ１阻害剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3118732A1 (de) * 1981-05-12 1982-12-02 Hoechst Ag, 6000 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
PL238158A1 (en) * 1981-09-08 1984-11-19 Lilly Co Eli Method of obtaining new cephalosporin derivatives
DE3207840A1 (de) * 1982-03-04 1983-09-15 Hoechst Ag, 6230 Frankfurt "cephalosporinderivate und verfahren zu ihrer herstellung"
US4500526A (en) * 1982-06-28 1985-02-19 Bristol-Myers Company Cephalosporin derivatives
JPS5910593A (ja) * 1982-06-28 1984-01-20 Bristol Mayers Kenkyusho Kk セフアロスポリン誘導体

Also Published As

Publication number Publication date
JPS60105685A (ja) 1985-06-11
GB8425453D0 (en) 1984-11-14
HU195512B (en) 1988-05-30
GB2148289A (en) 1985-05-30
DK489184D0 (da) 1984-10-12
HUT35687A (en) 1985-07-29
GB2181136A (en) 1987-04-15
ES8602816A1 (es) 1985-11-16
FI844000A0 (fi) 1984-10-11
AU574107B2 (en) 1988-06-30
GB2181136B (en) 1988-05-25
AU3418984A (en) 1985-04-26
EP0138552A3 (fr) 1986-03-19
PH21040A (en) 1987-07-03
SU1360587A3 (ru) 1987-12-15
ZA847926B (en) 1986-05-28
PT79357A (en) 1984-11-01
CA1225390A (fr) 1987-08-11
EP0138552A2 (fr) 1985-04-24
NZ209833A (en) 1988-04-29
GB8627171D0 (en) 1986-12-10
PT79357B (en) 1986-11-20
DK489184A (da) 1985-04-18
KR850002992A (ko) 1985-05-28
FI844000L (fi) 1985-04-18
FI844000A7 (fi) 1985-04-18
ES536728A0 (es) 1985-11-16
GB2148289B (en) 1987-09-23
GR80670B (en) 1985-02-18

Similar Documents

Publication Publication Date Title
AU582121B2 (en) Improvements in or relating to cephalosporins
GB2181136B (en) Improvements on or relating to 3-bicyclicpyridinium-methyl cephalosporins
GB2150409B (en) Improvements relating to smoking-article mouthpiece-elements
GB8400450D0 (en) Cephalosporins preparation
CS709284A2 (en) Zpusob pripravy novych kondenzovanych derivatu as triazinu
ZA852420B (en) Cephalosporins
GB8405879D0 (en) Cephalosporin c
IE832471L (en) Cephalosporins
IE830645L (en) Cephalosporins
IE842550L (en) Cephalosporins
IE842639L (en) Cephalosporins
IE841885L (en) 3-exomethylene cephalosporins
IE840893L (en) Cephalosporins
IE840897L (en) Benzothienylglycyl cephalosporins
IE842549L (en) Cephalosporins
IE840898L (en) Naphthylglycyl cephalosporins
IE812817L (en) Cephalosporins
PH16704A (en) Cephalosporins
IE811983L (en) Cephalosporins
IE810658L (en) Cephalosporins
IE811249L (en) Cephalosporins
IE812816L (en) Cephalosporins
IE812115L (en) Cephalosporins
GB8309527D0 (en) Penicillins
GB8331353D0 (en) Penicillins